Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5358-5366

  Kashii, Yoshiro ^a,b   Giorda, Roberto ^b   Herberman, Ronald B ^b   Whiteside, Theresa L ^b   Vujanovic, Nikola L ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; LYMPHOTOXIN; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL DESTRUCTION;

ANTIGENS, CD; ANTIGENS, CD70; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CD30 LIGAND; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; RNA, MESSENGER; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033571332     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Beutler, B., and C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667.
2. Gruss, H. J. 1996. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int. J. Clin. Lab. Res. 26:143.
3. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
4. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175.
5. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
6. Kitson, J., T. Raven, Y.-P. Jiang, D. V. Goeddel, K. M. Giles, K.-T. Pun, C. J. Grinham, R. Brown, and S. Farow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature 384:372.
7. Pan, G., K. O'Rourke, A. M. Chinalyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276:111.
8. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. Wood, A. D. Goddard, P. Godowski, and A. Ashkenazi. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
9. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signaling. Cell 81:479.
10. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Fergusson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
11. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867.
12. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159.
13. Wiley, S. R., K. Schooley, P. J. Smolak, W.S. Din, C.-P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
14. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793.
15. Lee, S. Y., C. G. Park, and Y. Choi. 1996. T cell receptor-dependent cell death of T cell hybridomas mediated by CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183:669.
16. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
17. Vujanovic, N. L., P. Basse, R. B. Herberman, and T. L. Whiteside. 1996. Anti-tumor functions of natural killer cells and control of metastases. Methods Companion Methods Enzymol. 9:394.
18. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:735.
19. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
20. Oshimi, Y., S. Oda, Y. Honda, S. Nagata, and S. Miyazaki. 1996. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157:2909.
21. Zamai, L., M. Ahmad, I. M. Bennet, L. Azzoni, E. S. Alnemri, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:2375.
22. Vitolo, D., N. L. Vujanovic, H. Rabinowich, M. Schlesinger, R. B. Herberman, and T. L. Whiteside. 1993. Rapid IL-2-induced adherence of human natural killer cells: expression of mRNA for cytokines and IL-2 receptors in adherent NK cells. J. Immunol. 151:1926.
23. Ware, C. F., P. D. Crowe, M. H. Grayson, M. J. Androlewicz, and J. L. Browning. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881.
24. Montel, A. H., M. R. Bochan, J. A. Hobbis, D. H. Lynch, and Z. Brahmi. 1995. Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 166:236.
25. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. H. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317.
26. Miyake, M., A. Horiuchi, K. Kimura, Y. Abe, S. Kimura, and Y. Hitsumoto. 1992. Correlation between killing activity towards the murine L929 cell line and expression of membrane-associated lymphotoxin-related molecule of human lymphokine-activated killer cells. Eur. J. Immunol. 22:2147.
27. Vujanovic, N. L., S. Nagashima, R. B. Herberman, and T. L. Whiteside. 1996. Nonsecretory apoptotic killing by human NK cells. J. Immunol. 157:1117.
28. Vujanovic, N. L., and T. L. Whiteside. 1995. Selection of lymphocyte subsets for immunotherapy. In Methods in Cell Transplantation. C. Ricordi, ed. R.G. Landes Publisher, Austin, p. 271.
29. Vujanovic, N. L., H. Rabinowich, Y. J. Lee, L. Jost, R. B. Herberman, and T. L. Whiteside. 1993. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell. Immunol. 151:133.
30. Heo, D. S., J.-G. Park, K. Hata, R. Day, R. B. Herberman, and T. L. Whiteside. 1990. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res. 50:3681.
31. Thilenius, A. R., K. Braun, and J. H. Russel. 1997. Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants. Eur. J. Immunol. 27:1108.
32. Ossina, N. K., A. Cannas, V. S. Powers, P. A. Fitzpatrick, J. D. Knight, J. R. Gilbert, E. M. Shekhtman, and L. D. Tomei. 1997. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272:16351.
33. Ribeiro, P., N. Renard, K. Warzocha, C. Charlot, L. Jeandenant, E. Callet-Bauchu, B. Coiffier, and G. Salles. 1998. CD40 regulation of death domains containing receptors and their ligands on lymphoma B cells. Br. J. Haematol. 103:684.
34. Lee, R. K., J. Spielman, D. Y. Zhao, K. J. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157:1919.
35. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
36. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V. K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran.1990. A novel addition to the T cell repertory: cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J. Exp. Med. 171:941.
37. Kiener, P. A., P. M. Davis, B. M. Rankin, S. J. Klebanoff, J. A. Ledbetter, G. C. Starling, and W. C. Liles. 1997. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol.